Search results
Is Sanofi SA (NASDAQ:SNY) the Best International Pharmaceutical Dividend Stock?
Insider Monkey via Yahoo Finance· 9 hours agoWe recently compiled a list of 12 Best International Dividend Stocks to Buy Now. Since Sanofi SA...
XML Financial LLC Sells 5,445 Shares of Sanofi (NASDAQ:SNY)
ETF DAILY NEWS· 18 hours agoXML Financial LLC trimmed its holdings in shares of Sanofi (NASDAQ:SNY – Free Report) by 54.8% in the 4th quarter, HoldingsChannel.com reports. The institutional investor ...
Regeneron (REGN), SNY Win FDA Nod for Kevzara Label Expansion
Zacks via Yahoo Finance· 8 hours agoRegeneron Pharmaceuticals, Inc. REGN and partner Sanofi SNY announced that the FDA has approved a...
Moderna Says Combination Flu And Covid Vaccine Beat Out Rivals From Sanofi, GSK
Investor's Business Daily· 1 day agoModerna stock toppled Monday after the biotech company said its combination Covid and flu vaccine...
Bull Market and Beyond: 3 Stocks Just Waiting to Soar
The Motley Fool via AOL· 17 hours agoThe agreement offers Novavax $500 million up front as well as other payments that could total $700...
Charles River (CRL) Partners to Reduce Animal Research Usage
Zacks via Yahoo Finance· 13 hours agoEach of them presently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 4 days agoInstitutional support is a good sign. But the number of funds that own shares has declined every...
My Novavax stock price forecast was correct: what next now? | Invezz
Invezz· 6 days agoNovavax (NASDAQ: NVAX) stock price has gone parabolic this year, making it one of the...
Health Care Roundup: Market Talk
The Wall Street Journal· 3 hours agoThe brokerage initiates coverage of the stock with an add rating and a target price of THB58.00. In addition to the younger generation and females, males...
Novavax, With A 369% Gain, Reverses Bullish Gains After Key FDA Move
Investor's Business Daily· 5 days agoSanofi will pay Novavax $500 million up front. Milestone, regulatory and other payments could add...